世界のニコチンアミドリボシド(NR)市場レポート、歴史と予測 2018-2029Global Nicotinamide Riboside (NR) Market Report, History and Forecast 2018-2029 COVID-19のパンデミックとロシア・ウクライナ戦争の影響により、ニコチンアミドリボシド(NR)の世界市場は、2022年に2146万米ドルと推定され、2023年から2029年の予測期間中に8.32%のCAGRで成長し、2029年まで... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーCOVID-19のパンデミックとロシア・ウクライナ戦争の影響により、ニコチンアミドリボシド(NR)の世界市場は、2022年に2146万米ドルと推定され、2023年から2029年の予測期間中に8.32%のCAGRで成長し、2029年までに3876万米ドルの改訂サイズに達すると予測されている。ニコチンアミドリボシド(NR)の北米市場は、2022年に978万ドルと評価され、2023年から2029年の予測期間中に8.49%のCAGRで、2029年までに1790万ドルに達するだろう。 ニコチンアミドリボシド(NR)のアジア太平洋市場は、2022年に655万ドルと評価され、2023年から2029年の予測期間中に9.08%のCAGRで、2029年までに1226万ドルに達するだろう。 ニコチンアミドリボシド(NR)のヨーロッパ市場は、2022年に359万ドルと評価され、2023年から2029年の予測期間中に7.35%のCAGRで、2029年までに626万ドルに達するだろう。 レポートの範囲 本レポートは、ニコチンアミドリボシド(NR)の世界市場を量的・質的分析の両面から包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、ニコチンアミドリボシド(NR)に関する情報に基づいたビジネス上の意思決定を行うのに役立つことを目的としています。 ニコチンアミドリボシド(NR)の市場規模、推計、予測は、2022年を基準年とし、2018年から2029年までの期間の履歴と予測データを考慮した販売量(MT)と収益(百万ドル)で提供します。本レポートでは、世界のニコチンアミドリボシド(NR)市場を包括的に区分しています。製品タイプ別、用途別、プレイヤー別の地域別市場規模も掲載しています。COVID-19とロシア・ウクライナ戦争の影響は市場規模を推定する際に考慮した。 市場のより詳細な理解のために、本レポートは競合状況、主要競合企業のプロフィール、それぞれの市場ランクを提供している。また、技術動向や新製品開発についても論じている。 本レポートは、読者が潜在的な利益を高めるために、業界内の競争と競争環境に対する戦略を理解するのに役立ちます。また、世界のニコチンアミドリボシド(NR)市場の競争環境に焦点を当て、主要企業の市場シェア、業界ランキング、競合エコシステム、市場実績、新製品開発、経営状況、事業拡大、買収などを詳細に紹介し、読者が主要な競合企業を特定し、市場の競争パターンを深く理解するのに役立ちます。 市場細分化 本レポートでは、ニコチンアミドリボシド(NR)をメーカー別、タイプ別、用途別、地域別、国別に分類し、2022年を基準年とした過去と予測期間(2018-2022年、2023-2029年)の市場規模(金額、数量、平均価格)とCAGRを提供しています。また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場に対する魅力的な投資提案マトリクスを解説しています。 企業別 クロマデックス ジェネックス・フォーミュラ 山東天明製薬 ボンタック ロンガーライブテック 天台バイオテクノロジー エンザイムワークス 蘇州マイランドファーマ&ニュートリション 深センEjionバイオテクノロジー 浙江佳華 威泰医薬 タイプ別セグメント 純度98%以下 純度>98 用途別セグメント 健康サプリメント 医薬品添加物 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 インド タイ 欧州 ドイツ フランス 英国 イタリア ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ 中東 アフリカ 主な章立て 第一章:本レポートの調査範囲、タイプ別市場セグメントのエグゼクティブサマリー、北米、欧州、アジア太平洋、ラテンアメリカ、中東&アフリカの市場規模セグメントを紹介します。 第二章:ニコチンアミドリボシド(NR)メーカーの競争環境、価格、売上高、市場シェアとランキング、最新の開発計画、合併、買収情報などの詳細分析。 第三章地域レベルでのニコチンアミドリボシド(NR)の販売、収益。各地域の市場規模と発展の可能性を定量的に分析し、今後の発展展望、世界の市場空間を紹介。 第4章:用途別市場セグメント、北米、欧州、アジア太平洋、ラテンアメリカ、中東&アフリカの市場規模セグメントを紹介します。 第五章、第六章、第七章、第八章、第九章北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東&アフリカ、国別の売上高と収益。 第10章主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第11章産業チェーン、主要原材料、製造コスト、市場ダイナミクスを分析。市場力学、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。 第12章販売チャネル、流通業者、顧客の分析 第十三章調査結果と結論。 目次1 Nicotinamide Riboside (NR) Market Overview 11.1 Nicotinamide Riboside (NR) Product Overview 1 1.2 Nicotinamide Riboside (NR) Market by Type 3 1.3 Global Nicotinamide Riboside (NR) Market Size by Type 3 1.3.1 Global Nicotinamide Riboside (NR) Market Size Overview by Type (2018-2029) 4 1.3.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Type (2018-2023) 5 1.3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Type (2024-2029) 6 1.4 Key Regions Market Size by Type 8 1.4.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 8 1.4.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 9 1.4.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 11 1.4.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 13 1.4.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 15 2 Nicotinamide Riboside (NR) Market Competition by Company 18 2.1 Global Top Players by Nicotinamide Riboside (NR) Sales (2018-2023) 18 2.2 Global Top Players by Nicotinamide Riboside (NR) Revenue (2018-2023) 19 2.3 Global Top Players by Nicotinamide Riboside (NR) Price (2018-2023) 20 2.4 Global Top Manufacturers Nicotinamide Riboside (NR) Manufacturing Base Distribution, Sales Area 21 2.5 Nicotinamide Riboside (NR) Market Competitive Situation and Trends 22 2.5.1 Nicotinamide Riboside (NR) Market Concentration Rate (2018-2023) 22 2.5.2 Global 3 and 6 Largest Manufacturers by Nicotinamide Riboside (NR) Sales and Revenue in 2022 23 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2022) 24 2.7 Date of Key Manufacturers Established 25 3 Nicotinamide Riboside (NR) Status and Outlook by Region 26 3.1 Global Nicotinamide Riboside (NR) Market Size and CAGR by Region: 2018 VS 2022 VS 2029 26 3.2 Global Nicotinamide Riboside (NR) Historic Market Size by Region 26 3.2.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023) 26 3.2.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023) 27 3.2.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2018-2023) 28 3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Region 28 3.3.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029) 28 3.3.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029) 29 3.3.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2024-2029) 29 4 Nicotinamide Riboside (NR) by Application 31 4.1 Nicotinamide Riboside (NR) Market by Application 31 4.1.1 Health Supplement 31 4.1.2 Pharmaceutical Additives 32 4.2 Global Nicotinamide Riboside (NR) Market Size by Application 33 4.2.1 Global Nicotinamide Riboside (NR) Market Size Overview by Application (2018-2029) 34 4.2.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Application (2018-2023) 35 4.2.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Application (2024-2029) 36 4.3 Key Regions Market Size by Application 38 4.3.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 38 4.3.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 39 4.3.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 41 4.3.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 43 4.3.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 45 5 North America Nicotinamide Riboside (NR) by Country 48 5.1 North America Nicotinamide Riboside (NR) Historic Market Size by Country 48 5.1.1 North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 48 5.1.2 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 48 5.1.3 North America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 49 5.2 North America Nicotinamide Riboside (NR) Forecasted Market Size by Country 49 5.2.1 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 49 5.2.2 North America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 50 6 Europe Nicotinamide Riboside (NR) by Country 51 6.1 Europe Nicotinamide Riboside (NR) Historic Market Size by Country 51 6.1.1 Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 51 6.1.2 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 51 6.1.3 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 52 6.2 Europe Nicotinamide Riboside (NR) Forecasted Market Size by Country 53 6.2.1 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 53 6.2.2 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 53 7 Asia-Pacific Nicotinamide Riboside (NR) by Region 55 7.1 Asia-Pacific Nicotinamide Riboside (NR) Historic Market Size by Region 55 7.1.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 55 7.1.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023) 55 7.1.3 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023) 56 7.2 Asia-Pacific Nicotinamide Riboside (NR) Forecasted Market Size by Region 57 7.2.1 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029) 57 7.2.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029) 57 8 Latin America Nicotinamide Riboside (NR) by Country 59 8.1 Latin America Nicotinamide Riboside (NR) Historic Market Size by Country 59 8.1.1 Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 59 8.1.2 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 59 8.1.3 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 60 8.2 Latin America Nicotinamide Riboside (NR) Forecasted Market Size by Country 60 8.2.1 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 60 8.2.2 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 61 9 Middle East and Africa Nicotinamide Riboside (NR) by Country 62 9.1 Middle East and Africa Nicotinamide Riboside (NR) Historic Market Size by Country 62 9.1.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 62 9.1.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 62 9.1.3 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 63 9.2 Middle East and Africa Nicotinamide Riboside (NR) Forecasted Market Size by Country 63 9.2.1 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 63 9.2.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 64 10 Company Profiles 65 10.1 ChromaDex 65 10.1.1 ChromaDex Company Information 65 10.1.2 ChromaDex Introduction and Business Overview 65 10.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 66 10.1.4 ChromaDex Nicotinamide Riboside (NR) Products Offered 67 10.1.5 ChromaDex Recent Development 67 10.2 Genex Formulas 68 10.2.1 Genex Formulas Company Information 69 10.2.2 Genex Formulas Introduction and Business Overview 69 10.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 69 10.2.4 Genex Formulas Nicotinamide Riboside (NR) Products Offered 70 10.3 Shandong Tianming Pharmaceutical 71 10.3.1 Shandong Tianming Pharmaceutical Company Information 71 10.3.2 Shandong Tianming Pharmaceutical Introduction and Business Overview 71 10.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 72 10.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Products Offered 73 10.4 Bontac 73 10.4.1 Bontac Company Information 73 10.4.2 Bontac Introduction and Business Overview 74 10.4.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 75 10.4.4 Bontac Nicotinamide Riboside (NR) Products Offered 75 10.5 Longer Livetech 75 10.5.1 Longer Livetech Company Information 76 10.5.2 Longer Livetech Introduction and Business Overview 76 10.5.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 77 10.5.4 Longer Livetech Nicotinamide Riboside (NR) Products Offered 77 10.6 Tiantai Biotechnology 77 10.6.1 Tiantai Biotechnology Company Information 78 10.6.2 Tiantai Biotechnology Introduction and Business Overview 78 10.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 79 10.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Products Offered 79 10.7 EnzymeWorks 80 10.7.1 EnzymeWorks Company Information 80 10.7.2 EnzymeWorks Introduction and Business Overview 81 10.7.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 81 10.7.4 EnzymeWorks Nicotinamide Riboside (NR) Products Offered 82 10.8 Suzhou MyLand Pharm & Nutrition 82 10.8.1 Suzhou MyLand Pharm & Nutrition Company Information 82 10.8.2 Suzhou MyLand Pharm & Nutrition Introduction and Business Overview 83 10.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 84 10.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Products Offered 84 10.9 Shenzhen Ejion Biotechnology 85 10.9.1 Shenzhen Ejion Biotechnology Company Information 85 10.9.2 Shenzhen Ejion Biotechnology Introduction and Business Overview 85 10.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 86 10.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Products Offered 86 10.10 Zhejiang Jiahua 87 10.10.1 Zhejiang Jiahua Company Information 87 10.10.2 Zhejiang Jiahua Introduction and Business Overview 88 10.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 89 10.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Products Offered 89 10.11 Weitai Pharmaceutical 89 10.11.1 Weitai Pharmaceutical Company Information 90 10.11.2 Weitai Pharmaceutical Introduction and Business Overview 90 10.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 91 10.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Products Offered 91 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 93 11.1 Nicotinamide Riboside (NR) Key Raw Materials 93 11.1.1 Key Raw Materials 93 11.1.2 Key Raw Materials Price 93 11.1.3 Raw Materials Key Suppliers 94 11.2 Manufacturing Cost Structure 94 11.2.1 Raw Materials 95 11.2.2 Labor Cost 95 11.2.3 Manufacturing Expenses 95 11.3 Nicotinamide Riboside (NR) Industrial Chain Analysis 95 11.4 Nicotinamide Riboside (NR) Market Dynamics 96 11.4.1 Nicotinamide Riboside (NR) Industry Trends 96 11.4.2 Nicotinamide Riboside (NR) Market Drivers 96 11.4.3 Nicotinamide Riboside (NR) Market Challenges 97 11.4.4 Nicotinamide Riboside (NR) Market Restraints 97 12 Marketing Strategy Analysis, Distributors 98 12.1 Sales Channel 98 12.2 Nicotinamide Riboside (NR) Distributors 99 12.3 Nicotinamide Riboside (NR) Downstream Customers 100 13 Research Findings and Conclusion 101 14 Appendix 102 14.1 Research Methodology 102 14.1.1 Methodology/Research Approach 102 14.1.2 Data Source 105 14.2 Author Details 108 14.3 Disclaimer 110
SummaryDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nicotinamide Riboside (NR) was estimated at US$ 21.46 million in the year 2022, is projected to reach a revised size of US$ 38.76 million by 2029, growing at a CAGR of 8.32 % during the forecast period 2023-2029. Table of Contents1 Nicotinamide Riboside (NR) Market Overview 11.1 Nicotinamide Riboside (NR) Product Overview 1 1.2 Nicotinamide Riboside (NR) Market by Type 3 1.3 Global Nicotinamide Riboside (NR) Market Size by Type 3 1.3.1 Global Nicotinamide Riboside (NR) Market Size Overview by Type (2018-2029) 4 1.3.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Type (2018-2023) 5 1.3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Type (2024-2029) 6 1.4 Key Regions Market Size by Type 8 1.4.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 8 1.4.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 9 1.4.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 11 1.4.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 13 1.4.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023) 15 2 Nicotinamide Riboside (NR) Market Competition by Company 18 2.1 Global Top Players by Nicotinamide Riboside (NR) Sales (2018-2023) 18 2.2 Global Top Players by Nicotinamide Riboside (NR) Revenue (2018-2023) 19 2.3 Global Top Players by Nicotinamide Riboside (NR) Price (2018-2023) 20 2.4 Global Top Manufacturers Nicotinamide Riboside (NR) Manufacturing Base Distribution, Sales Area 21 2.5 Nicotinamide Riboside (NR) Market Competitive Situation and Trends 22 2.5.1 Nicotinamide Riboside (NR) Market Concentration Rate (2018-2023) 22 2.5.2 Global 3 and 6 Largest Manufacturers by Nicotinamide Riboside (NR) Sales and Revenue in 2022 23 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2022) 24 2.7 Date of Key Manufacturers Established 25 3 Nicotinamide Riboside (NR) Status and Outlook by Region 26 3.1 Global Nicotinamide Riboside (NR) Market Size and CAGR by Region: 2018 VS 2022 VS 2029 26 3.2 Global Nicotinamide Riboside (NR) Historic Market Size by Region 26 3.2.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023) 26 3.2.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023) 27 3.2.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2018-2023) 28 3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Region 28 3.3.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029) 28 3.3.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029) 29 3.3.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2024-2029) 29 4 Nicotinamide Riboside (NR) by Application 31 4.1 Nicotinamide Riboside (NR) Market by Application 31 4.1.1 Health Supplement 31 4.1.2 Pharmaceutical Additives 32 4.2 Global Nicotinamide Riboside (NR) Market Size by Application 33 4.2.1 Global Nicotinamide Riboside (NR) Market Size Overview by Application (2018-2029) 34 4.2.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Application (2018-2023) 35 4.2.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Application (2024-2029) 36 4.3 Key Regions Market Size by Application 38 4.3.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 38 4.3.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 39 4.3.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 41 4.3.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 43 4.3.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023) 45 5 North America Nicotinamide Riboside (NR) by Country 48 5.1 North America Nicotinamide Riboside (NR) Historic Market Size by Country 48 5.1.1 North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 48 5.1.2 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 48 5.1.3 North America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 49 5.2 North America Nicotinamide Riboside (NR) Forecasted Market Size by Country 49 5.2.1 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 49 5.2.2 North America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 50 6 Europe Nicotinamide Riboside (NR) by Country 51 6.1 Europe Nicotinamide Riboside (NR) Historic Market Size by Country 51 6.1.1 Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 51 6.1.2 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 51 6.1.3 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 52 6.2 Europe Nicotinamide Riboside (NR) Forecasted Market Size by Country 53 6.2.1 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 53 6.2.2 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 53 7 Asia-Pacific Nicotinamide Riboside (NR) by Region 55 7.1 Asia-Pacific Nicotinamide Riboside (NR) Historic Market Size by Region 55 7.1.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 55 7.1.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023) 55 7.1.3 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023) 56 7.2 Asia-Pacific Nicotinamide Riboside (NR) Forecasted Market Size by Region 57 7.2.1 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029) 57 7.2.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029) 57 8 Latin America Nicotinamide Riboside (NR) by Country 59 8.1 Latin America Nicotinamide Riboside (NR) Historic Market Size by Country 59 8.1.1 Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 59 8.1.2 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 59 8.1.3 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 60 8.2 Latin America Nicotinamide Riboside (NR) Forecasted Market Size by Country 60 8.2.1 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 60 8.2.2 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 61 9 Middle East and Africa Nicotinamide Riboside (NR) by Country 62 9.1 Middle East and Africa Nicotinamide Riboside (NR) Historic Market Size by Country 62 9.1.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 62 9.1.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023) 62 9.1.3 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023) 63 9.2 Middle East and Africa Nicotinamide Riboside (NR) Forecasted Market Size by Country 63 9.2.1 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029) 63 9.2.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029) 64 10 Company Profiles 65 10.1 ChromaDex 65 10.1.1 ChromaDex Company Information 65 10.1.2 ChromaDex Introduction and Business Overview 65 10.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 66 10.1.4 ChromaDex Nicotinamide Riboside (NR) Products Offered 67 10.1.5 ChromaDex Recent Development 67 10.2 Genex Formulas 68 10.2.1 Genex Formulas Company Information 69 10.2.2 Genex Formulas Introduction and Business Overview 69 10.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 69 10.2.4 Genex Formulas Nicotinamide Riboside (NR) Products Offered 70 10.3 Shandong Tianming Pharmaceutical 71 10.3.1 Shandong Tianming Pharmaceutical Company Information 71 10.3.2 Shandong Tianming Pharmaceutical Introduction and Business Overview 71 10.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 72 10.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Products Offered 73 10.4 Bontac 73 10.4.1 Bontac Company Information 73 10.4.2 Bontac Introduction and Business Overview 74 10.4.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 75 10.4.4 Bontac Nicotinamide Riboside (NR) Products Offered 75 10.5 Longer Livetech 75 10.5.1 Longer Livetech Company Information 76 10.5.2 Longer Livetech Introduction and Business Overview 76 10.5.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 77 10.5.4 Longer Livetech Nicotinamide Riboside (NR) Products Offered 77 10.6 Tiantai Biotechnology 77 10.6.1 Tiantai Biotechnology Company Information 78 10.6.2 Tiantai Biotechnology Introduction and Business Overview 78 10.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 79 10.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Products Offered 79 10.7 EnzymeWorks 80 10.7.1 EnzymeWorks Company Information 80 10.7.2 EnzymeWorks Introduction and Business Overview 81 10.7.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 81 10.7.4 EnzymeWorks Nicotinamide Riboside (NR) Products Offered 82 10.8 Suzhou MyLand Pharm & Nutrition 82 10.8.1 Suzhou MyLand Pharm & Nutrition Company Information 82 10.8.2 Suzhou MyLand Pharm & Nutrition Introduction and Business Overview 83 10.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 84 10.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Products Offered 84 10.9 Shenzhen Ejion Biotechnology 85 10.9.1 Shenzhen Ejion Biotechnology Company Information 85 10.9.2 Shenzhen Ejion Biotechnology Introduction and Business Overview 85 10.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 86 10.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Products Offered 86 10.10 Zhejiang Jiahua 87 10.10.1 Zhejiang Jiahua Company Information 87 10.10.2 Zhejiang Jiahua Introduction and Business Overview 88 10.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 89 10.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Products Offered 89 10.11 Weitai Pharmaceutical 89 10.11.1 Weitai Pharmaceutical Company Information 90 10.11.2 Weitai Pharmaceutical Introduction and Business Overview 90 10.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023) 91 10.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Products Offered 91 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 93 11.1 Nicotinamide Riboside (NR) Key Raw Materials 93 11.1.1 Key Raw Materials 93 11.1.2 Key Raw Materials Price 93 11.1.3 Raw Materials Key Suppliers 94 11.2 Manufacturing Cost Structure 94 11.2.1 Raw Materials 95 11.2.2 Labor Cost 95 11.2.3 Manufacturing Expenses 95 11.3 Nicotinamide Riboside (NR) Industrial Chain Analysis 95 11.4 Nicotinamide Riboside (NR) Market Dynamics 96 11.4.1 Nicotinamide Riboside (NR) Industry Trends 96 11.4.2 Nicotinamide Riboside (NR) Market Drivers 96 11.4.3 Nicotinamide Riboside (NR) Market Challenges 97 11.4.4 Nicotinamide Riboside (NR) Market Restraints 97 12 Marketing Strategy Analysis, Distributors 98 12.1 Sales Channel 98 12.2 Nicotinamide Riboside (NR) Distributors 99 12.3 Nicotinamide Riboside (NR) Downstream Customers 100 13 Research Findings and Conclusion 101 14 Appendix 102 14.1 Research Methodology 102 14.1.1 Methodology/Research Approach 102 14.1.2 Data Source 105 14.2 Author Details 108 14.3 Disclaimer 110
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ケミカル)の最新刊レポートQYResearch社の化学・材料分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/23 10:26 157.72 円 164.94 円 201.11 円 |